Reneural Secures £475K Funding to Advance Disruptive NeuroRehabilitation Platform
Reneural Raises £200K in Pre-seed Funding Round Led by SFC Capital, with an Additional £275K in Support from Innovate UK
CardioCrown Explores Global Opportunities for Neurorehabilitation
Engaging Key Stakeholders in New York to Drive Wider Adoption of NeuroVive
CardioCrown Showcases Neurovive’s VR Therapies at Sussex Hospital
Introducing therapists to the tools that can support their therapy sessions
CardioCrown Concludes Strategic Planning Phase with SBC Catalyzer
Charting a 17-Month Roadmap for NeuroVive’s Development and Commercialisation
Strengthening Ties: CardioCrown’s Impactful Engagement with the Irish MedTech Sector
Exploring New Opportunities through the Global Business Innovation Programme
CardioCrown Advances to Semifinals of Discovery Spark and Shines at GIANT Health
Paving the Way for Innovation in Healthcare: CardioCrown Excels at Discovery Spark and GIANT Health Event
CardioCrown Founders Run for a Cause, Raising Funds for Stroke Association
CardioCrown founders go the extra mile to raise funds and awareness for the Stroke Association, finishing their first half marathon and surpassing fundraising goals.
Brunel’s Research, Innovate, and Emerge (RIEm) Program Empowers CardioCrown in HealthTech Innovation
RIEm Supports SMEs with Innovation Funding, Research Collaboration, and Strategic Guidance for Business Growth
CardioCrown Showcases Groundbreaking Stroke Rehabilitation Solution at BioSeed Summer Event 2024
Victor Harbari Highlights CardioCrown’s Innovative Approach and Opens New Investment Round at OBN’s Life Sciences Event